National Vaccine Information Center Your Health. Your Family. Your Choice. |
MedAlerts.org |
Case Details |
Administered by: Other Purchased by: ?
Life Threatening? Yes Write-up: Brain Death; In the following months my daughter developed a condition of acute ITP (Immune thrombocytopenic purpura); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent. A 5-year-old female patient (not pregnant) received BNT162b2 (COMIRNATY), on 26Jan2022 as dose 1, single (Lot number: FP8290) at the age of 5 years for covid-19 immunisation. The patient''s relevant medical history was not reported. There were no concomitant medications. The following information was reported: IMMUNE THROMBOCYTOPENIA (death, hospitalization, life threatening) with onset May2022, outcome "fatal", described as "In the following months my daughter developed a condition of acute ITP (Immune thrombocytopenic purpura)"; BRAIN DEATH (death, hospitalization, medically significant, life threatening) with onset 05Jun2022, outcome "fatal". The patient was hospitalized for immune thrombocytopenia, brain death (hospitalization duration: 18 day(s)). The events "in the following months my daughter developed a condition of acute itp (immune thrombocytopenic purpura)" and "brain death" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of immune thrombocytopenia, brain death. The patient date of death was 05Jun2022. Reported cause of death: "Brain death", "Immune thrombocytopenic purpura". No autopsy was performed.; Reported Cause(s) of Death: Immune thrombocytopenic purpura; Brain death | ||||||||||||||||
Link To This Search Result:
https://medalerts.org/vaersdb/findfield.php?IDNUMBER=2410237
Copyright ©
2024 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166